Global plasma protein therapeutics market size to garner significant returns by 2026

The research report on ‘global plasma protein therapeutics market’ presents a strategic workplan for entrepreneurs and investors for the period 2021-2026.


Pune, India, Nov. 18, 2021 (GLOBE NEWSWIRE) -- According to MarketStudyReport, global plasma protein therapeutics market was remunerated at USD 25.4 billion in 2020 and is anticipated to record strong growth rate over 2021-2026, eventually accumulating significant revenues by the end of study period.

The document also offers a detailed analysis of the sub-markets, including product type, application range, and geographical landscape, thus revealing the prominent avenues for investment in the upcoming years. An exclusive study of industry value chain, from the suppliers to the distributors and consumers, is entailed in the report as well.

Introduction of innovative plasma-derived therapies is majorly driving the market growth. In addition, growing incidence of genetic disorders and rising use of these therapeutics in pharmaceuticals are augmenting the market scope. Immense demand for targeted therapies over the past two decades as well as increasing trend towards early detection of diseases are positively swaying the industry dynamics.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/4331017/

Notably, plasma protein therapeutics are used for treatments of several diseases like hemostasis. Rising awareness regarding utilization of various protein components that are highly effective and promote a modernized way of treatment are significantly influencing the market trends.

Furthermore, surging demand for advanced therapeutic remedies which are developed from the plasma protein due to its efficacy, along with government initiatives for advancing healthcare industry, and favorable reimbursement policies by health insurance companies are propelling the market development.

Market segmentation overview

Based on product type, global plasma protein therapeutics industry is segmented into albumin, immunoglobulin, factor viii, and others. Considering the application range, the marketplace is categorized into hemophilia, ITP, PID, and others.

Geographical outlook

The regional analysis of the marketplace covers North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. The country level scrutiny includes Canada, United States, Germany, France, U.K, Spain, Japan, China, Australia, and South Korea.

Summarizing the competitive scope

Prominent players swaying the global plasma protein therapeutics industry dynamics are ADMA Biologics Inc., Kedrion Biopharma Inc., Octapharma AG, Pfizer Inc., Grifols S.A., Bayer AG, Biotest AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., and CSL Behring.

These behemoths are investing in R&D activities in order to introduce product innovations and gain edge over the competitors. Also, strategies like collaboration, acquisitions, mergers, and partnerships are being undertaken by the companies to expand their customer base and amplify revenues.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/global-plasma-protein-therapeutics-market-2021-edition-analysis-by-product-ig-albumin-factor-viii-others-application-hemophilia-pid-itp-others-application-by-region-by-country-market-insights-and-forecast-with-impact-of-covid-19-2021-2026

Global Plasma Protein Therapeutics Market by Product Type (Revenue, USD Million, 2016-2026)

  • Albumin
  • Immunoglobulin
  • Factor VIII
  • Others

Global Plasma Protein Therapeutics Market by Application Range (Revenue, USD Million, 2016-2026)

  • Hemophilia
  • ITP
  • PID
  • Others

Global Plasma Protein Therapeutics Market Regional Terrain (Revenue, USD Million, 2016-2026)

Asia Pacific

  • China
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Spain
  • Rest of Europe

  • Rest of the World

Global Plasma Protein Therapeutics Market Competitive Dashboard (Revenue, USD Million, 2016-2026)

  • ADMA Biologics Inc.
  • Kedrion Biopharma Inc.
  • Octapharma AG
  • Pfizer Inc.
  • Grifols S.A.
  • Bayer AG
  • Biotest AG
  • Takeda Pharmaceutical Company Limited
  • Baxter International Inc.
  • CSL Behring

Table of Content:

1. Report Scope and Methodology

1.1 Scope of the Report

1.2 Research Methodology

1.3 Executive Summary

2. Strategic Recommendations

3. Plasma Protein Therapeutics Market: Product Outlook

4. Global Plasma Protein Therapeutics Market: Sizing and Forecast

4.1 Global Plasma Protein Therapeutics Market Size, By Value, Year 2016-2026

5. Global Plasma Protein Therapeutics Market Segmentation - By Product, By Application

5.1 Competitive Scenario of Global Plasma Therapeutics Protein Therapeutics Market: By Product

5.1.1 Immunoglobulin - Market Size and Forecast (2016-2026)

5.1.2 Albumin - Market Size and Forecast (2016-2026)

5.1.3 Factor VIII  - Market Size and Forecast (2016-2026)

5.1.4 Others - Market Size and Forecast (2016-2026)

5.2 Competitive Scenario of Global Plasma Protein Market: By Application

5.2.1 Hemophilia - Market Size and Forecast (2016-2026)

6. Global Plasma Protein Therapeutics Market: Regional Analysis

6.1 Competitive Scenario of Global Plasma Protein Therapeutics Market: By Region

7. North America Plasma Protein Therapeutics Market: An Analysis (2016-2026)

7.1 North America Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value

7.2 North America Plasma Protein Therapeutics Market - Prominent Companies

7.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)                                  

7.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others)  

7.5 North America Plasma Protein Therapeutics Market: Country Analysis    

8. Europe Plasma Protein Therapeutics Market: An Analysis (2016-2026)

8.1 Europe Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value

8.2 Europe Plasma Protein Therapeutics Market - Prominent Companies

8.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)?                                              

8.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others)?    

8.5 Europe Plasma Protein Market: Country Analysis    

9. Asia Pacific Plasma Protein Therapeutics Market: An Analysis (2016-2026)

9.1 Asia Pacific Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value

9.2 Asia Pacific Plasma Protein Therapeutics Market - Prominent Companies

9.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)?                                               

9.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others)? 

9.5 Asia Pacific Plasma Protein Market: Country Analysis?     

10. Global Plasma Protein Therapeutics Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Trends

11. Market Attractiveness

11.1 Market Attractiveness Chart of Global Plasma Protein Therapeutics Market - By Product, 2026

11.2 Market Attractiveness Chart of Global Plasma Protein Therapeutics Market - By Application, 2026

11.3 Market Attractiveness Chart of Global Plasma Protein Therapeutics Market - By Region, 2026

12. Competitive Landscape

12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers

12.2 Product Pipeline of Leading Plasma Protein Companies

12.3 Market Share Analysis

13. Company Analysis
Related Report:

Platelet and Plasma Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026

The platelet and plasma market is set to record considerable growth in coming years due to the increasing occurrence of chronic diseases across the globe. In modern day medical therapies, patients can receive either a pint of complete blood or just specific components present within the blood that are essential to treat particular conditions. This treatment approach, known as a blood component treatment, enables several patients to receive more benefit from a single pint of the donated whole blood. Regionally, the LATAM market held a market value of over $460 million in 2019, owing to the growing incidence of hemophilia, autoimmune disorder, as well as other infectious diseases.

About US:

Market Study Report is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.


 

Contact Data